Clinical Course and Treatment of COVID-19 Inpatients in Hospital

COVID-19 Clinical Trial

Official title:

Clinical Course and Treatment of COVID-19 Inpatients in Hospital

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04527497
• Other study ID #: WI_20-1294
• Status: Completed
• Start date: August 1, 2020
• Est. completion date: August 31, 2021

Study information

• Verified date: October 2021
• Source: Wissenschaftliches Institut Bethanien e.V
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The study is an epidemiological observational study. It serves to collect data from patients with positive COVID-19 test results who are hospitalized. All data describing the course of the inpatient stay are recorded (Length of stay, course of therapy, medication, X-ray and CT results,ventilation mode and duration, laboratory). Furthermore, anthropometric data and information on COVID-19 symptoms is recorded.

Description:

The aim of this study is to describe the course of disease and the treatment of patients suffering from COVID-19 who are hospitalized and treated as inpatients:

1. Are there common features (previous illnesses, medication, age, BMI, etc.), which may influence the course of disease?

2. Are there therapeutic procedures that have a positive or negative impact on the course of the disease or the length of stay in the intensive care unit/ the duration of ventilation (early/late intubation, CPAP, NIV, ECMO)?

Recruitment information / eligibility

• Status: Completed
• Enrollment: 35
• Est. completion date: August 31, 2021
• Est. primary completion date: May 30, 2021
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• positive COVID-19 test result

• Age > 18 years

Exclusion Criteria:

• Age < 18 years

• negative COVID-19 test result

• lack of agreement

• Any medical, psychological or other condition, that restricts the ability of the person to be informed and to give the consent for voluntary participation in this trial

Related Conditions & MeSH terms

• COVID-19
• Disease Progression

Locations

Country	Name	City	State
Germany	Institut für Pneumologie an der Universität zu Köln / Wissenschaftliches Institut Bethanien für Pneumologie e.V.	Solingen	Nordrhein-Westfalen

Sponsors (1)

Lead Sponsor	Collaborator
Wissenschaftliches Institut Bethanien e.V

Country where clinical trial is conducted

Germany, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	convalescence/death	has patient died or has patient recovered	through study completion, an average of 2 months
Secondary	length of stay in the intensive care unit	length of stay in the intensive care unit	through study completion, an average of 2 months
Secondary	length of stay in hospital	length of stay in hospital	through study completion, an average of 2 months